Genmab A/S (GMAB) PT Raised to $36 at SunTrust; 'Product Potential, Pipeline and Platform'

June 1, 2020 11:00 AM

SunTrust analyst Asthika Goonewardene raised the price target on Genmab A/S (NASDAQ: GMAB) to $36.00 (from $30.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found